COMPASSIONATE USE – Treating Physician AgreementAgreement • September 17th, 2020
Contract Type FiledSeptember 17th, 2020Pre-Approval Access/Compassionate Use of Entrectinib for Patients with Solid Tumors harboring a NTRK Gene Fusion or Patients with Non-Small Cell Lung Cancer (NSCLC) harboring a ROS1 Gene Fusion (AG40852)